Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2025)
Beyond Air recorded quarterly Liabilities and Shareholders Equity of $36.8 million in Q4 2025, up 18.76% quarter-over-quarter from $31.0 million in Q3 2025, and up 7.7% year-over-year from $34.1 million in Q4 2024.
Beyond Air's Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $36.8 million for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity rose 7.7% year-over-year to $36.8 million; the TTM figure through Dec 2025 stood at $125.9 million (down 33.94% YoY), while the FY2025 annual figure was $30.1 million, down 47.22% from the prior year.
- Liabilities and Shareholders Equity came in at $36.8 million for Q4 2025 at Beyond Air, up from $31.0 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $99.3 million in Q4 2021 to a low of $28.1 million in Q2 2025.
- A 5-year average of $57.7 million and a median of $53.5 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity surged 300.17% in 2021 and plunged 47.22% in 2025, its largest moves.
- Beyond Air's Liabilities and Shareholders Equity stood at $99.3 million in 2021, then fell by 25.53% to $74.0 million in 2022, then retreated by 29.81% to $51.9 million in 2023, then tumbled by 34.23% to $34.1 million in 2024, then advanced by 7.7% to $36.8 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $36.8 million, $31.0 million, and $28.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 | 36.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.77 Mn |
| Sep 30, 2025 | 30.97 Mn |
| Jun 30, 2025 | 28.11 Mn |
| Mar 31, 2025 | 30.06 Mn |
| Dec 31, 2024 | 34.14 Mn |
| Sep 30, 2024 | 53.01 Mn |
| Jun 30, 2024 | 46.50 Mn |
| Mar 31, 2024 | 56.96 Mn |
| Dec 31, 2023 | 51.91 Mn |
| Sep 30, 2023 | 58.01 Mn |
| Jun 30, 2023 | 73.04 Mn |
| Mar 31, 2023 | 68.75 Mn |
| Dec 31, 2022 | 73.96 Mn |
| Sep 30, 2022 | 82.04 Mn |
| Jun 30, 2022 | 91.90 Mn |
| Mar 31, 2022 | 99.20 Mn |
| Dec 31, 2021 | 99.31 Mn |
| Sep 30, 2021 | 54.06 Mn |
| Jun 30, 2021 | 44.17 Mn |
| Mar 31, 2021 | 40.53 Mn |
| Dec 31, 2020 | 24.82 Mn |
| Sep 30, 2020 | 24.47 Mn |
| Jun 30, 2020 | 26.88 Mn |
| Mar 31, 2020 | 27.43 Mn |
| Dec 31, 2019 | 16.76 Mn |
| Sep 30, 2019 | 11.14 Mn |
| Jun 30, 2019 | 13.12 Mn |
| Mar 31, 2019 | 9.43 Mn |
| Dec 31, 2018 | 3.91 Mn |
| Sep 30, 2018 | 5.27 Mn |
| Jun 30, 2018 | 7.10 Mn |
| Mar 31, 2018 | 9.36 Mn |
| Dec 31, 2017 | 2.19 Mn |
| Sep 30, 2017 | 4.08 Mn |
| Jun 30, 2017 | 5.49 Mn |
| Mar 31, 2017 | 7.40 Mn |
| Dec 31, 2016 | 236,000.00 |
| Dec 31, 2015 | 5,559.00 |